Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2008

s -- (129,527)

Construction deposits (2,206,145) --

Contractor deposits 101,801 412,802

Addition to construction in progress (9,722,463) (12,961,091)

Proceeds from sale of equipment 61,152 --

Purchase of equipment and automobiles (360,192) (1,158,813)

Net cash used in investing (9,542,428) (18,525,646)

CASH FLOW FROM FINANCING ACTIVITIES:

Loan from (repayment to) related

parties 7,400,000 (843,115)

Payments on long term debt, related

party (1,065,000) --

Proceeds from share subscription in

subsidiary -- 18,000,130

Proceeds from joint venture investor

in Dongfeng 2,828 -

Payment to minority interest

shareholder (5,070,091) (6,676,102)

Net cash provided by (used

in) financing activities 1,267,737 10,480,913

EFFECTOF EXCHANGE RATE CHANGES ON CASH 3,053,932 1,272,215

INCREASE (DECREASE) IN CASH (6,340,515) 3,085,516

CASH, beginning of period 54,081,848 55,214,540

CASH, end of period $ 47,741,333 58,300,056

Supplemental disclosures of cash flow

information

Cash pain during the year for:

Interest (net of amount capitalized) $ 132,662 --

Income taxes $ 1,822,619 1,370,002

Note 1.

On December 20, 2007, the Company's subsidiary, Tianshi International

Holdings Group Ltd. (''Tianshi Holdings''),
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
2. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Yongye Biotechnology International Retains CCG Investor Relations
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
11. New Book on the Business of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),t...nouncedthatithassubmittedaMAAtotheEuropeanMedicine...lacementtherapyindevelopment,forthetreatmentofType...nforvelaglucerasealfathathasbeensubmitted,withprev... Basedonaglobalsupplyshortageofthecurrentlyapprove...
(Date:11/24/2009)... Abstracts Service (CAS), the global expert on che...ice is now the world,s leading producer of patent ... Japan,s patent office, the World Intellectual Pro...atent and Trademark Office (USPTO) for more than a...6, and exceeded Japan for the first time on a mont...
(Date:11/23/2009)...sional carbon layer in which the carbon atoms are ...ycomb. Carbon nanotubes are rolled-up sheets of gr...aphite. Graphene boasts some very special characte...ent thermal conductor, and reconciles such conflic...dition, graphene is impermeable to gases, which ma...
(Date:11/23/2009)...--ImmuneDesignC or p.(IDC)announcedtodaythatDr.Bru...terhasasuccessfultrackrec or dinbiotechnologyexecu...eratZymoGenetics,inSeattle,WAandChiefScientificOff...to: http://www.newscom.com/cgi-bin/prnh/20091123/S...xecutiveOfficercommented,"IamdelightedtowelcomeDr....
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
...PDS , an IT firm that operates in the Madison and ...nesses who are having trouble keeping track of all...e. , ,"We,ve had IT managers tell us it,s just to...working, especially as more employees are allowed ... infrastructure services for PDS, in a press relea...
... It turns out that "free" services can be profitab...k, LinkedIn, announced that this month it would hi...profitability. , ,After a few years of hooking up ...ntroduced premium services, ranging in cost from $... offerings has exceeded expectations of even the m...
...cientists say it,s not a matter of if, but when. A... the least, keep large sections of the population ...ions and cause infrastructure outages information... coordinating both public efforts and business. , ...ely, they could be left with more than an interrup...
Other Biology Technology:Free can be profitable 2IT critical in pandemic response, but many are not paying attention 2IT critical in pandemic response, but many are not paying attention 3IT critical in pandemic response, but many are not paying attention 4
(Date:11/23/2009)...a biomedical engineer and cardiologist Tzung "John...ians distinguish cardiac emergencies requiring imm...th drugs and lifestyle change. , Angiograms, ima...eeding the heart, offer an inside view of the inte...en revealing deposits of a dangerous fatty substan...
(Date:11/23/2009)... , , , , , , , ...Dr Andrew Marshall, from the Environment Departmen...ry of Kinyongia magomberae and his wider work in...e information. , , , , , ... , , , , , , A new species of chamele...
(Date:11/23/2009)...n Institute for Child Health Research has found ev...mption in pregnancy affects child behaviour in dif... online in the international journal Addiction . ...was drawn from a random sample of more than 2000 m...after the baby,s delivery, and were then followed ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3New study links alcohol in pregnancy to child behavior problems 2Type of Knee Surgery Makes Difference in Football Career 51400 1Type of Knee Surgery Makes Difference in Football Career 51400 2Obama 3A Too Many Still Die from Diseases That Shouldnt Kill Them 51397 1Obama 3A Too Many Still Die from Diseases That Shouldnt Kill Them 51397 2Mayo Clinic study using structural MRI may help accurately diagnose dementia patients 51393 1Mayo Clinic study using structural MRI may help accurately diagnose dementia patients 51393 2
...loped "self-exploding" microcapsules that could on...the human body weeks or even months after injectio...nd the Universit? Catholique de Louvain, is schedu...the American Chemical Society,s journal Biomacrom...ch release their drug cargo only when exposed to u...
...team believes that changes in behaviour among the ...HIV infection in Eastern Zimbabwe. , Research publ... almost 50 percent decline in HIV prevalence in so...le delaying when they first have sex and having fe...fell most steeply at young ages, with a drop in pr...
...ould provide the next generation of human therapeu...nom has been identified by Queensland University o...dly stop excessive bleeding during vascular surger...xin, Factor X (Factor Ten), was identified by PhD ...e Sciences who studied the venom of eight of Austr...
Other Biology News:HIV decline in Zimbabwe linked to behavioural change 2Taipan venom no snake oil 2
Dynabeads Mouse Pan B (B220) from Dynal Biotech
Rabbit Anti-Human ALS2CR2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-Human GORASP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
FailSafe PCR 2X PreMix B from EPICENTRE Biotechnologies
Biology Products: